Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 14/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1978510 | 0.96 | CNR2 (0.68) | CNR2ALDH1A1HPGDKDM4ENPC1 | |
| SCHEMBL1978626 | 0.92 | CNR2 (0.62) | CNR2ALDH1A1HPGDKDM4ENPC1 | |
| SCHEMBL25515583 | 0.89 | CNR2 (0.56) | CNR2ALDH1A1HPGDKDM4ENPC1 | |
| SCHEMBL13640281 | 0.87 | CNR2 (0.56) | CNR2ALDH1A1HPGDKDM4ENPC1 | |
| SCHEMBL28946332 | 0.87 | KDM4E (0.54) | CNR2ALDH1A1HPGDKDM4ENPC1 | |
| SCHEMBL1980186 | 0.86 | CNR2 (0.47) | CNR2ALDH1A1HPGDKDM4ENPC1 | |
| SCHEMBL13640229 | 0.86 | CNR2 (0.66) | CNR2ALDH1A1HPGDKDM4ENPC1 | |
| SCHEMBL24494776 | 0.84 | CNR2 (0.53) | CNR2ALDH1A1HPGDKDM4ENPC1 | |
| SCHEMBL22828459 | 0.83 | CNR2 (0.47) | CNR2ALDH1A1HPGDKDM4ENPC1 | |
| SCHEMBL1979651 | 0.83 | ALDH1A1 (0.47) | CNR2ALDH1A1HPGDKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220179309-A1 | PHOTOINITIATOR COMPOSITION CONTAINING ACYLCARBAZOLE DERIVATIVE AND CARBAZOLYL OXIME ESTER, AND USE THEREOF IN PHOTOCURABLE COMPOSITION | IGM (ANQING) HIGH TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220179309-A1 | PHOTOINITIATOR COMPOSITION CONTAINING ACYLCARBAZOLE DERIVATIVE AND CARBAZOLYL OXIME ESTER, AND USE THEREOF IN PHOTOCURABLE COMPOSITION | CYP2C19, ALAD, PPOX | CNR2 416/4885ALDH1A1 1503/4885HPGD 1124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.